Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Mineralys Therapeutics In...

    NASDAQ: MLYS · Real-Time Price · USD
    14.51
    0.38 (2.69%)
    At close: Aug 15, 2025, 12:42 PM

    Mineralys Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 43K n/a n/a n/a
    Gross Profit
    		 -43K n/a n/a n/a
    Operating Income
    		 -192.4M -84.66M -31.48M -18.73M
    Interest Income
    		 14.59M 12.76M 1.68M n/a
    Pretax Income
    		 -177.81M -71.9M -29.8M -19.41M
    Net Income
    		 -177.81M -71.9M -29.8M -19.41M
    Selling & General & Admin
    		 23.82M 14.3M 5.23M 2.42M
    Research & Development
    		 168.58M 70.36M 26.25M 16.31M
    Other Expenses
    		 n/a n/a n/a n/a
    Operating Expenses
    		 192.4M 84.66M 31.48M 18.73M
    Interest Expense
    		 n/a n/a 1.68M 27K
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 192.4M 84.66M 31.48M 18.73M
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 48.54M 36.19M 5.17M 4.98M
    Shares Outstanding (Diluted)
    		 48.54M 36.19M 5.17M 4.98M
    EPS (Basic)
    		 -3.66 -1.99 -5.77 -3.89
    EPS (Diluted)
    		 -3.66 -1.99 -5.77 -3.89
    EBITDA
    		 -192.36M -84.66M -31.48M -19.38M
    EBIT
    		 -192.4M -84.66M -29.8M -19.38M
    Depreciation & Amortization
    		 43K n/a 228.49K n/a

    Add to Watchlist